Biohit Oyj (HEL:BIOBV)
Finland · Delayed Price · Currency is EUR 2.680
-0.020 (-0.74%)
Aug 7, 2026, 5:26 PM EET
Biohit Oyj Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 16.1 | 15.7 | 14.28 | 13.08 | 10.95 | 9.36 |
Revenue Growth | 2.55% | 9.92% | 9.23% | 19.41% | 16.98% | 31.42% |
Gross Profit Gross Profit Growth | 11.3 | 10.8 | 9.34 | 8.46 | 7.11 | 5.92 |
Operating Income Operating Income Growth | 3.2 | 2.9 | 2.56 | 1.83 | 1.13 | -1.48 |
Net Income Net Income Growth | 3.1 | 2.7 | 2.57 | 1.85 | 0.6 | -1.5 |
Earnings Per Share EPS Growth | 0.20 | 0.18 | 0.17 | 0.12 | 0.04 | -0.10 |
EPS Growth | 11.11% | 5.88% | 41.67% | 200.00% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Finland Finland Growth | 0.25 | 0.21 | 0.21 | 0.24 | 0.24 |
Europe, Other Europe, Other Growth | 5.55 | 5.74 | 5.7 | 4.59 | 4.29 |
North and South America North and South America Growth | 0.35 | 0.3 | 0.32 | 0.27 | 0.28 |
Asia Asia Growth | 6.89 | 5.17 | 4.57 | 4.73 | 3.61 |
Other Countries Other Countries Growth | 2.69 | 2.86 | 2.28 | 1.12 | 0.94 |
Total Total Growth | 15.73 | 14.28 | 13.08 | 10.95 | 9.36 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1.6 | 3.54 | 3.75 | 3.27 | 2.12 | 1.1 |
Total Debt Total Debt Growth | 1.4 | 1.59 | 0.59 | 0.7 | 0.94 | 0.22 |
Net Cash (Debt) Net Cash Growth | 0.2 | 1.95 | 3.16 | 2.57 | 1.18 | 0.88 |
Net Cash Growth | -89.74% | -38.25% | 22.93% | 117.90% | 33.83% | 34.09% |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.13 | 0.21 | 0.17 | 0.08 | 0.06 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1.1 | -0.75 | 0.59 | 0.9 | 1.85 | -0.44 |
Capital Expenditures CapEx Growth | -0.9 | -0.62 | -0.4 | -0.25 | -0.06 | -0.03 |
Free Cash Flow Free Cash Flow Growth | -2 | -1.36 | 0.18 | 0.65 | 1.79 | -0.48 |
Free Cash Flow Growth | - | - | -71.86% | -63.44% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.19% | 68.79% | 65.39% | 64.73% | 64.94% | 63.19% |
Operating Margin | 19.88% | 18.47% | 17.90% | 13.96% | 10.31% | -15.81% |
Pretax Margin | 19.88% | 18.47% | 20.08% | 16.79% | 7.93% | -13.94% |
Profit Margin | 19.25% | 17.20% | 17.99% | 14.16% | 5.49% | -16.02% |
FCF Margin | -12.42% | -8.68% | 1.29% | 5.00% | 16.34% | -5.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.54 | 20.50 | 13.47 | 15.71 | 39.25 | - |
Forward PE | 15.76 | 23.81 | 14.54 | 17.14 | - | - |
P/FCF Ratio | - | - | 188.95 | 43.56 | 13.20 | - |
PS Ratio | 2.53 | 3.57 | 2.43 | 2.18 | 2.16 | 2.95 |